ISRG - Intuitive Surgical Inc Stock Price, Fair Value and News

381.06USD-7.59 (-1.95%)Delayed as of 08 May 2024, 01:19 pm ET

Market Summary

USD381.06-7.59

Delayedas of 08 May 2024, 01:19 pm

-1.95%

ISRG Alerts

4 major insider sales recently.

Big jump in Earnings (Y/Y)

ISRG Stock Price

View Fullscreen

ISRG RSI Chart

ISRG Valuation

Market Cap

137.8B

Price/Earnings (Trailing)

69.34

Price/Sales (Trailing)

18.83

EV/EBITDA

65.03

Price/Free Cashflow

80.7

ISRG Price/Sales (Trailing)

ISRG Profitability

Operating Margin

85.95%

EBT Margin

28.36%

Return on Equity

14.15%

Return on Assets

12.56%

Free Cashflow Yield

1.24%

ISRG Fundamentals

ISRG Revenue

Revenue (TTM)

7.3B

Rev. Growth (Yr)

11.46%

Rev. Growth (Qtr)

-1.96%

ISRG Earnings

Earnings (TTM)

2.0B

Earnings Growth (Yr)

53.36%

Earnings Growth (Qtr)

-10.11%

Breaking Down ISRG Revenue

52 Week Range

282.50385.90

(Low)(High)

Last 7 days

4.8%

Last 30 days

0.0%

Last 90 days

-0.7%

Trailing 12 Months

28.2%

How does ISRG drawdown profile look like?

ISRG Financial Health

Current Ratio

5.55

ISRG Investor Care

Shares Dilution (1Y)

1.23%

Diluted EPS (TTM)

5.54

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	7.3B	0	0	0
2023	6.4B	6.7B	6.9B	7.1B
2022	5.9B	6.0B	6.1B	6.2B
2021	4.6B	5.2B	5.5B	5.7B
2020	4.6B	4.4B	4.3B	4.4B
2019	3.9B	4.0B	4.2B	4.5B
2018	3.3B	3.5B	3.6B	3.7B
2017	2.8B	2.9B	3.0B	3.1B
2016	2.4B	2.5B	2.6B	2.7B
2015	2.2B	2.3B	2.3B	2.4B
2014	2.1B	2.1B	2.1B	2.1B
2013	2.3B	2.3B	2.3B	2.3B
2012	1.9B	2.0B	2.1B	2.2B
2011	1.5B	1.5B	1.6B	1.8B
2010	1.2B	1.3B	1.3B	1.4B
2009	875.1M	916.5M	960.6M	1.1B
2008	0	692.2M	783.5M	874.9M
2007	0	0	0	600.8M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Intuitive Surgical Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 03, 2024	rubash mark j	sold	-649,420	380	-1,709	-
May 03, 2024	rubash mark j	acquired	505,727	295	1,709	-
Apr 29, 2024	desantis robert	acquired	93,855	249	376	evp & chief strategy & corp op
Apr 29, 2024	desantis robert	sold	-70,573	375	-188	evp & chief strategy & corp op
Apr 26, 2024	desantis robert	acquired	408,950	272	1,498	evp & chief strategy & corp op
Apr 26, 2024	desantis robert	sold	-440,771	370	-1,190	evp & chief strategy & corp op
Apr 25, 2024	reed monica p	acquired	-	-	569	-
Apr 25, 2024	beery joseph c	acquired	-	-	569	-
Apr 25, 2024	nachtsheim jami k	acquired	-	-	569	-
Apr 25, 2024	rubash mark j	acquired	-	-	569	-

Which funds bought or sold ISRG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	First Business Financial Services, Inc.	unchanged	-	-	504,353	0.06%
May 06, 2024	Metis Global Partners, LLC	added	0.2	967,335	6,186,300	0.22%
May 06, 2024	Kades & Cheifetz LLC	reduced	-1.76	37,249	266,991	0.17%
May 06, 2024	Candriam S.C.A.	reduced	-16.65	-1,455,010	102,593,000	0.66%
May 06, 2024	Quantbot Technologies LP	sold off	-100	-730,722	-	-%
May 06, 2024	IFG Advisory, LLC	sold off	-100	-331,286	-	-%
May 06, 2024	Diligent Investors, LLC	added	22.39	337,388	1,090,710	0.27%
May 06, 2024	Pinnacle Wealth Management, LLC	reduced	-1.48	425,903	2,999,960	3.13%
May 06, 2024	Wealthspire Advisors, LLC	reduced	-18.03	-12,876	411,861	-%
May 06, 2024	Valmark Advisers, Inc.	added	3.14	61,489	340,823	0.01%

Are Funds Buying or Selling ISRG?

Are funds buying ISRG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ISRG

No. of Funds

Unveiling Intuitive Surgical Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	price t rowe associates inc /md/	4.8%	16,990,447	SC 13G/A
Feb 13, 2024	vanguard group inc	8.63%	30,375,212	SC 13G/A
Jan 25, 2024	blackrock inc.	8.4%	29,575,972	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	5.9%	20,823,995	SC 13G/A
Feb 09, 2023	vanguard group inc	8.33%	29,425,186	SC 13G/A
Feb 03, 2023	blackrock inc.	8.0%	28,447,145	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	6.9%	24,756,021	SC 13G/A
Feb 07, 2022	blackrock inc.	7.4%	26,538,660	SC 13G/A
Feb 16, 2021	price t rowe associates inc /md/	8.1%	9,599,898	SC 13G/A
Feb 10, 2021	vanguard group inc	7.76%	9,127,891	SC 13G/A

Recent SEC filings of Intuitive Surgical Inc

View All Filings

Date Filed	Form Type	Document
May 07, 2024	144	Notice of Insider Sale Intent
May 06, 2024	4	Insider Trading
May 03, 2024	144	Notice of Insider Sale Intent
Apr 30, 2024	8-K	Current Report
Apr 30, 2024	4	Insider Trading
Apr 29, 2024	4	Insider Trading
Apr 29, 2024	144	Notice of Insider Sale Intent
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading

Peers (Alternatives to Intuitive Surgical Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	184.5B	40.3B	-4.60%	-4.35%	32.81	4.58	-2.84%	-3.08%
BDX	68.5B	19.7B	-3.65%	-5.69%	51.42	3.48	4.82%	-17.56%
ALGN	21.6B	3.9B	-9.77%	-6.38%	46.66	5.51	5.72%	46.72%
BAX	18.4B	14.9B	-15.25%	-20.81%	6.95	1.24	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	5.58%	23.16%	31.71	2.8	6.16%	35.06%
HSIC	9.1B	12.5B	-1.81%	-10.76%	23.5	0.73	-0.61%	-18.83%
BIO	8.2B	2.7B	-13.87%	-26.12%	-12.81	3.06	-4.68%	82.43%
XRAY	5.9B	3.9B	-12.53%	-31.61%	-62.76	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.62%	22.51%	-215.76	8.88	30.82%	65.57%
PDCO	2.3B	6.6B	-0.84%	-0.80%	12.05	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-6.97%	-19.30%	-1.87	0.4	7.94%	-1661.78%
ANIK	420.5M	166.7M	10.85%	9.31%	-5.09	2.52	6.67%	-456.34%
ANGO	245.9M	324.0M	-12.80%	-31.58%	-1.28	0.76	-3.19%	-337.41%
APYX	48.8M	52.3M	-6.00%	-59.48%	-2.61	0.93	17.61%	19.28%
AEMD	3.4M	3.7M	-25.71%	271.43%	-0.27	0.89	5.77%	8.23%

Intuitive Surgical Inc News

Latest updates

Intuitive Surgical Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-2.0%	1,891	1,928	1,744	1,756	1,696	1,655	1,557	1,522	1,488	1,551	1,403	1,464	1,292	1,329	1,078	852	1,100	1,278	1,128	1,099	974
Gross Profit	-2.5%	1,245	1,277	1,167	1,172	1,113	1,111	1,052	1,023	1,010	1,061	971	1,024	903	896	724	503	738	896	786	759	670
Operating Expenses	-6.2%	776	827	701	709	725	738	653	626	602	610	529	513	486	480	454	422	455	498	420	400	417
S&GA Expenses	-13.3%	492	567	452	464	481	494	436	418	391	427	363	350	326	330	299	279	308	342	284	279	273
R&D Expenses	9.4%	285	260	249	244	245	244	217	207	211	183	166	162	160	150	155	143	147	157	136	121	144
EBITDA Margin	3.1%	0.28*	0.27*	0.31*	0.30*	0.29*	0.30*	0.32*	0.33*	0.36*	0.38*	0.39*	0.39*	0.35*	0.32*	-	-	-	-	-	-	-
Income Taxes	90.6%	-8.90	-94.80	102	73.00	61.00	58.00	78.00	93.00	33.00	72.00	74.00	3.00	14.00	73.00	38.00	37.00	-8.10	69.00	0.00	75.00	-24.30
Earnings Before Taxes	4.4%	539	516	522	499	422	395	403	407	402	454	461	526	449	437	355	107	308	432	399	392	280
EBT Margin	3.1%	0.28*	0.27*	0.27*	0.26*	0.25*	0.26*	0.27*	0.29*	0.31*	0.33*	0.34*	0.34*	0.30*	0.28*	-	-	-	-	-	-	-
Net Income	-10.1%	545	606	416	421	355	325	324	308	366	381	381	517	426	365	314	68.00	314	358	397	318	307
Net Income Margin	7.6%	0.27*	0.25*	0.22*	0.21*	0.20*	0.21*	0.23*	0.24*	0.28*	0.30*	0.31*	0.31*	0.26*	0.24*	-	-	-	-	-	-	-
Free Cashflow	16.3%	265	228	548	666	371	438	383	447	223	568	501	543	478	628	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	2.5%	15,828	15,442	14,713	13,903	13,053	12,974	13,261	13,705	13,678	13,555	12,935	12,297	11,540	11,169	10,618	10,104	9,891	9,733	9,131	8,532	8,235
Current Assets	-3.2%	7,633	7,888	8,903	8,032	6,877	6,253	6,293	6,293	5,803	5,845	5,728	6,017	6,066	6,626	6,300	5,899	4,692	4,663	4,317	4,072	4,025
Cash Equivalents	3.3%	2,840	2,750	3,602	3,435	2,166	1,601	1,554	1,551	1,118	1,306	1,362	1,631	1,418	1,639	1,386	2,052	1,239	1,183	985	805	891
Inventory	6.4%	1,299	1,221	1,148	1,005	947	893	837	724	653	587	585	570	577	602	663	646	620	596	580	513	468
Net PPE	7.4%	3,800	3,538	3,077	2,831	2,580	2,374	2,244	2,109	1,968	1,876	1,738	1,651	1,593	1,577	1,510	1,450	1,369	1,273	1,137	1,032	935
Goodwill	-0.1%	348	349	348	349	349	349	348	349	343	344	344	344	345	337	336	337	335	307	305	245	248
Liabilities	-12.8%	1,782	2,044	2,089	1,944	1,759	1,861	1,687	1,623	1,522	1,604	1,475	1,418	1,350	1,410	1,331	1,337	1,361	1,449	1,354	1,252	1,195
Current Liabilities	-17.1%	1,375	1,659	1,676	1,538	1,307	1,422	1,233	1,175	1,112	1,150	1,027	1,005	905	965	895	925	946	1,030	931	808	740
Shareholder's Equity	4.9%	13,963	13,308	12,539	11,960	11,294	11,113	11,574	12,082	12,157	11,952	11,460	10,880	10,190	9,759	9,287	8,766	8,531	8,285	7,777	7,280	7,040
Retained Earnings	6.9%	5,068	4,743	4,209	3,808	3,397	3,500	4,018	4,683	4,858	4,761	4,390	4,023	3,515	3,261	2,937	2,633	2,571	2,495	2,143	1,819	1,696
Additional Paid-In Capital	3.8%	8,903	8,576	8,386	8,151	7,928	7,704	7,685	7,484	7,355	7,164	7,015	6,804	6,627	6,445	6,304	6,085	5,927	5,757	5,601	5,430	5,329
Accumulated Depreciation	-100.0%	-	1,562	-	-	-	1,238	-	-	-	969	-	-	-	758	-	-	-	563	-	-	-
Shares Outstanding	0.7%	355	352	352	351	350	350	355	358	358	356	357	356	354	-	-	-	-	-	-	-	-
Minority Interest	-6.6%	84.00	90.00	85.00	81.00	77.00	71.00	59.00	59.00	55.00	50.00	49.00	42.00	37.00	28.00	29.00	26.00	24.00	21.00	16.00	14.00	16.00
Float	-	-	-	-	119,600	-	-	-	71,400	-	-	-	108,700	-	-	-	66,400	-	-	-	59,900	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	16.3%	265	228	548	666	371	438	383	447	223	568	501	543	478	628	275	230	353	553	396	316	333
Share Based Compensation	1.9%	153	150	156	147	140	128	138	127	121	118	120	108	103	103	106	96.00	91.00	89.00	89.00	82.00	76.00
Cashflow From Investing	87.7%	-128	-1,044	-446	558	573	575	545	466	-214	-641	-838	-384	-597	-334	-1,025	537	-117	-406	-216	-222	-308
Cashflow From Financing	-48.3%	-46.70	-31.50	62.00	63.00	-381	-963	-926	-482	-199	19.00	68.00	58.00	-102	-39.80	85.00	48.00	-178	51.00	1.00	-178	-41.80
Buy Backs	-100.0%	-	66.00	-	-	350	1,001	1,000	500	107	-	-	-	-	34.00	-	-	100	-	70.00	200	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ISRG Income Statement

2024-03-31

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 1,890.6	$ 1,696.2
Cost of revenue:
Total cost of revenue	645.2	583.2
Gross profit	1,245.4	1,113.0
Operating expenses:
Selling, general and administrative	491.5	480.5
Research and development	284.5	244.9
Total operating expenses	776.0	725.4
Income from operations	469.4	387.6
Interest and other income, net	69.1	34.2
Income before taxes	538.5	421.8
Income tax expense (benefit)	(8.9)	61.0
Net income	547.4	360.8
Less: net income attributable to noncontrolling interest in joint venture	2.5	5.5
Net income attributable to Intuitive Surgical, Inc.	$ 544.9	$ 355.3
Net income per share attributable to Intuitive Surgical, Inc.:
Basic (in dollars per share)	$ 1.54	$ 1.01
Diluted (in dollars per share)	$ 1.51	$ 1.00
Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:
Basic (in shares)	353.5	350.2
Diluted (in shares)	360.5	356.0
Other comprehensive income, net of tax:
Unrealized gains on hedge instruments	$ 5.6	$ 2.5
Unrealized gains (losses) on available-for-sale securities	(4.2)	37.6
Foreign currency translation gains	1.8	14.2
Prior service cost for employee benefit plans	(0.1)	0.0
Other comprehensive income	3.1	54.3
Total comprehensive income	550.5	415.1
Less: comprehensive income attributable to noncontrolling interest	2.1	5.8
Total comprehensive income attributable to Intuitive Surgical, Inc.	548.4	409.3
Corporate Joint Venture
Operating expenses:
Less: net income attributable to noncontrolling interest in joint venture	2.5	5.5
Product
Revenue:
Total revenue	1,577.1	1,413.0
Cost of revenue:
Total cost of revenue	554.4	493.0
Service
Revenue:
Total revenue	313.5	283.2
Cost of revenue:
Total cost of revenue	$ 90.8	$ 90.2

ISRG Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,839.5	$ 2,750.1
Short-term investments	1,960.6	2,473.1
Accounts receivable, net	1,127.9	1,130.2
Inventory	1,299.3	1,220.6
Prepaids and other current assets	405.4	314.0
Total current assets	7,632.7	7,888.0
Property, plant, and equipment, net	3,799.6	3,537.6
Long-term investments	2,522.6	2,120.0
Deferred tax assets	917.8	910.5
Intangible and other assets, net	607.1	636.7
Goodwill	348.2	348.7
Total assets	15,828.0	15,441.5
Current liabilities:
Accounts payable	194.4	188.7
Accrued compensation and employee benefits	238.4	436.4
Deferred revenue	437.5	446.1
Other accrued liabilities	504.8	587.5
Total current liabilities	1,375.1	1,658.7
Other long-term liabilities	406.5	385.5
Total liabilities	1,781.6	2,044.2
Contingencies (Note 8)
Stockholders’ equity:
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of March 31, 2024, and December 31, 2023	0.0	0.0
Common stock, 600.0 shares authorized, $0.001 par value, 354.7 shares and 352.3 shares issued and outstanding as of March 31, 2024, and December 31, 2023, respectively	0.4	0.4
Additional paid-in capital	8,903.0	8,576.4
Retained earnings	5,067.9	4,743.0
Accumulated other comprehensive loss	(8.7)	(12.2)
Total Intuitive Surgical, Inc. stockholders’ equity	13,962.6	13,307.6
Noncontrolling interest in joint venture	83.8	89.7
Total stockholders’ equity	14,046.4	13,397.3
Total liabilities and stockholders’ equity	$ 15,828.0	$ 15,441.5

About Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

CEO	Dr. Gary S. Guthart Ph.D.
WEBSITE	intuitive.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	12120

Intuitive Surgical Inc Frequently Asked Questions

What is the ticker symbol for Intuitive Surgical Inc? What does ISRG stand for in stocks?

ISRG is the stock ticker symbol of Intuitive Surgical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Intuitive Surgical Inc (ISRG)?

As of Tue May 07 2024, market cap of Intuitive Surgical Inc is 137.82 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ISRG stock?

You can check ISRG's fair value in chart for subscribers.

What is the fair value of ISRG stock?

You can check ISRG's fair value in chart for subscribers. The fair value of Intuitive Surgical Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Intuitive Surgical Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ISRG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Intuitive Surgical Inc a good stock to buy?

The fair value guage provides a quick view whether ISRG is over valued or under valued. Whether Intuitive Surgical Inc is cheap or expensive depends on the assumptions which impact Intuitive Surgical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ISRG.

What is Intuitive Surgical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, ISRG's PE ratio (Price to Earnings) is 69.34 and Price to Sales (PS) ratio is 18.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ISRG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Intuitive Surgical Inc's stock?

In the past 10 years, Intuitive Surgical Inc has provided 0.258 (multiply by 100 for percentage) rate of return.